Marpai Confirms Revenue Guidance For Q2 2023 Of $9.5M-$9.8M
Portfolio Pulse from Happy Mohamed
Marpai, Inc. (NASDAQ:MRAI) has confirmed its Q2 2023 revenue guidance of $9.5M-$9.8M. The company also expects an improvement in Q2's EBITDA and net income compared to Q1 2023. This comes after the acquisition of Maestro Health and ongoing integration efforts. Despite flat revenues, cost-cutting efforts are showing results, as evidenced by the expected improvement in EBITDA.
June 29, 2023 | 12:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Marpai's confirmation of its Q2 2023 revenue guidance and expected improvement in EBITDA and net income could positively impact its stock. The successful integration of Maestro Health and cost-cutting efforts are also positive indicators.
Marpai's confirmation of its Q2 2023 revenue guidance and expected improvement in EBITDA and net income indicates a positive financial outlook, which could boost investor confidence and drive the stock price up. The successful integration of Maestro Health and cost-cutting efforts further strengthen the company's position.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100